Trials / Unknown
UnknownNCT04419012
Polish Atrial Fibrillation (POL-AF) Registry
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (estimated)
- Sponsor
- Jan Kochanowski University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of clinical characteristics and pharmacotherapy of hospitalized Polish patients with atrial fibrillation (AF).
Detailed description
Atrial fibrillation (AF) is a common arrhythmia associated with increased cardiovascular mortality. An important element of management of patients with AF is anticoagulation to prevent thromboembolic events. Non-vitamin K oral anticoagulants (NOACs) and vitamin K antagonists (VKAs) are two main drugs groups used in thromboembolic events prevention. Primary objective of the study is to assess the frequency of VKAs vs NOACs prescription in AF patients treatment of with OACs. Secondary objective of the study are as follows: assessment of the frequency of appropriate/inappropriate OACs prescription in AF patients and assesment of the number of patients with AF treated with apixaban, dabigatran and rivaroxaban with high thromboembolism risk according to CHA2DS2-VASc score. The POL-AF Registry is a multicenter prospective analysis of hospital records of patients with AF managed in ten cardiology centers. Collected data will include demographics, type of AF (valvular and non-valvular, as well as paroxysmal, persistent and permanent), medical history, laboratory tests, echocardiographic parameters and concomitant medications. Each patient will be evaluated regarding to common scales assessing risk of thromboembolic (CHA2DS2-VASc) and bleeding (HAS-BLED, modifiable and non-modifiable risk factors for bleeding in anticoagulated patients basing on the current guidelines for AF treatment) events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | observation | observation |
Timeline
- Start date
- 2019-01-06
- Primary completion
- 2020-06-30
- Completion
- 2020-12-31
- First posted
- 2020-06-05
- Last updated
- 2020-07-29
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04419012. Inclusion in this directory is not an endorsement.